← Leaderboards
Michael E Wechsler
Brigham And Women'S Hospital
$8,821,134
Attributed
$10,481,258
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2005–22$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$10,481,258 · 6
By mechanism
U01$5,804,033 · 1
UG1$2,271,973 · 1
U10$1,028,275 · 1
R21$687,377 · 1
K23$669,600 · 1
R13$20,000 · 1
Top collaborators
- Stanley J Szefler8 shared
- Monica Kraft1 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Edward A. Nardell$8,148,952
- Kathleen Mary Buchheit$1,302,645
- Steven A Shea$17,974,788
- Christopher Kabrhel$5,107,090
- Joshua A Boyce$54,050,346
Others in their field
Top investigators on “Asthma”
- James E. Gern · University Of Wisconsin-Madison$159,588,264
- William W. Busse · University Of Wisconsin Madison$104,093,792
- Scott T Weiss · University Of California, San Diego$98,211,117
- David T Mauger · Pennsylvania State Univ Hershey Med Ctr$79,309,576
- Fernando D Martinez · University Of Arizona$66,357,737
- Wanda Phipatanakul · Boston Children'S Hospital$50,505,446
Research focus
AsthmaClinical TrialsAdrenal Cortex HormonesResponseDesignDoseSymptomsSteroidsNitric OxideInflammationSputumProtocols DocumentationIl5 GeneBloodSerumHospitalizationAdverse EffectsPharmaceutical PreparationsAsthmatic PatientBaseEosinophilBiological MarkersCytokinePrimary Outcome
Grant awards (20)
Precision Interventions for Severe and/or Exacerbation Prone Asthma (PrecISE)$350,274
UG1 · FY2022 · HL · contact PI
Precision Interventions for Severe and/or Exacerbation Prone Asthma (PrecISE)$384,737
UG1 · FY2021 · HL · contact PI
Precision Interventions for Severe and/or Exacerbation Prone Asthma (PrecISE)$393,830
UG1 · FY2020 · HL · contact PI
Precision Interventions for Severe and/or Exacerbation Prone Asthma (PrecISE)$399,696
UG1 · FY2019 · HL · contact PI
Precision Interventions for Severe and/or Exacerbation Prone Asthma (PrecISE)$399,696
UG1 · FY2018 · HL · contact PI
Precision Interventions for Severe and/or Exacerbation Prone Asthma (PrecISE)$343,740
UG1 · FY2017 · HL · contact PI
Anti IL5 and Churg Strauss Syndrome: a double blind, placebo controlled trial$1,251,988
U01 · FY2016 · AI · contact PI
Anti IL5 and Churg Strauss Syndrome: a double blind, placebo controlled trial$1,474,019
U01 · FY2015 · AI · contact PI
Clinical Centers for the NHLBI Asthma Network (AsthmaNet)$336,493
U10 · FY2015 · HL · contact PI
58th Annual Aspen Lung Conference$20,000
R13 · FY2015 · HL · contact PI
Anti IL5 and Churg Strauss Syndrome: a double blind, placebo controlled trial$1,497,170
U01 · FY2014 · AI · contact PI
Clinical Centers for the NHLBI Asthma Network (AsthmaNet)$691,782
U10 · FY2014 · HL · contact PI
Anti IL5 and Churg Strauss Syndrome: a double blind, placebo controlled trial$1,580,856
U01 · FY2013 · AI · contact PI
The Reliability of the Placebo Effect in Asthma$338,614
R21 · FY2007 · AT · contact PI
The Reliability of the Placebo Effect in Asthma$348,763
R21 · FY2006 · AT · contact PI
Polymorphisms of Neural NOS and the Asthma Phenotype$133,920
K23 · FY2005 · HL
Polymorphisms of Neural NOS and the Asthma Phenotype$133,920
K23 · FY2004 · HL
Polymorphisms of Neural NOS and the Asthma Phenotype$133,920
K23 · FY2003 · HL
Polymorphisms of Neural NOS and the Asthma Phenotype$133,920
K23 · FY2002 · HL
Polymorphisms of Neural NOS and the Asthma Phenotype$133,920
K23 · FY2001 · HL